Learning from the QUEST multicentre feasibility randomization trials in breast reconstruction after mastectomy

Breast reconstruction aims to improve health‐related quality of life after mastectomy. However, evidence guiding patients and surgeons in shared decision‐making concerning the optimal type or timing of surgery is lacking.

[1]  Z. Winters,et al.  Role of acellular dermal matrix‐assisted implants in breast reconstruction , 2014, The British journal of surgery.

[2]  S. Cawthorn,et al.  Time to be BRAVE: is educating surgeons the key to unlocking the potential of randomised clinical trials in surgery? A qualitative study , 2013, Trials.

[3]  P. Harris,et al.  Post-mastectomy breast reconstruction , 2013, BMJ.

[4]  S. Cawthorn,et al.  Exploring inequalities in access to care and the provision of choice to women seeking breast reconstruction surgery: a qualitative study , 2013, British Journal of Cancer.

[5]  Jane M Blazeby,et al.  IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage , 2013, BMJ.

[6]  Z. Winters,et al.  The early development phases of a European Organisation for Research and Treatment of Cancer (EORTC) module to assess patient reported outcomes (PROs) in women undergoing breast reconstruction. , 2013, European journal of cancer.

[7]  Z. Winters,et al.  Integration of patient‐reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment , 2012, The British journal of surgery.

[8]  T. Zuiderent-Jerak,et al.  Guidelines should reflect all knowledge, not just clinical trials , 2012, BMJ : British Medical Journal.

[9]  车伯琛 Global Health 2011 , 2012 .

[10]  Z. Fedorowicz,et al.  Immediate versus delayed reconstruction following surgery for breast cancer. , 2011, The Cochrane database of systematic reviews.

[11]  M. Barry,et al.  Radiotherapy and breast reconstruction: a meta-analysis , 2011, Breast Cancer Research and Treatment.

[12]  Z. Winters,et al.  A Systematic Review of the Clinical Evidence to Guide Treatment Recommendations in Breast Reconstruction Based on Patient- Reported Outcome Measures and Health-Related Quality of Life , 2010, Annals of surgery.

[13]  J. Lyons,et al.  Complication Rates of Radiation on Tissue Expander and Autologous Tissue Breast Reconstruction , 2010, Annals of Surgical Oncology.

[14]  M. Trivella,et al.  Regional variation in use of immediate breast reconstruction after mastectomy for breast cancer in England. , 2010, European Journal of Surgical Oncology.

[15]  N. Devlin,et al.  Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making , 2010 .

[16]  J. Dewar,et al.  Effect of postoperative radiotherapy on autologous deep inferior epigastric perforator flap volume after immediate breast reconstruction , 2009, The British journal of surgery.

[17]  Clara N. Lee,et al.  Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review. , 2009, Journal of the American College of Surgeons.

[18]  D Brewster,et al.  Cancer prevalence in the United Kingdom: estimates for 2008 , 2009, British Journal of Cancer.

[19]  F. Hamdy,et al.  It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trials. , 2009, Social science & medicine.

[20]  Jonathan A Cook,et al.  The challenges faced in the design, conduct and analysis of surgical randomised controlled trials , 2009, Trials.

[21]  R. Fitzpatrick,et al.  A STRUCTURED REVIEW OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR BREAST CANCER , 2009 .

[22]  R. Fitzpatrick,et al.  A STRUCTURED REVIEW OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR HEART FAILURE , 2009 .

[23]  Chris Salisbury,et al.  Patients’ preferences within randomised trials: systematic review and patient level meta-analysis , 2008, BMJ : British Medical Journal.

[24]  G. Tienhoven,et al.  Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[25]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[26]  A. Fingerhut,et al.  Patient’s Preference and Randomization: New Paradigm of Evidence-based Clinical Research , 2005, World Journal of Surgery.

[27]  Benoit Nemery,et al.  Tactics of tobacco industry in Belgium (Rapid response letter) , 2005 .

[28]  E. Lim Need for expertise based randomised controlled trials , 2005, BMJ : British Medical Journal.

[29]  Jay R. Harris,et al.  Radiation therapy for invasive breast cancer: not just for local control. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[31]  G. Robb,et al.  Delayed-Immediate Breast Reconstruction , 2004, Plastic and reconstructive surgery.

[32]  F. Hamdy,et al.  Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. , 2003, Controlled clinical trials.

[33]  Mitsuru Sasako,et al.  Randomised trials in surgery: problems and possible solutions , 2002, BMJ : British Medical Journal.

[34]  Penny Hopwood,et al.  A body image scale for use with cancer patients. , 2001, European journal of cancer.

[35]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[37]  A. Kasuya EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[38]  G. Huston The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.